UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How Do We Want to Live?: We Decide Ourselves about Our Future

Grunder, Gerhard

1, 2022

Volltextzugriff (PDF)

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

Nature reviews. Drug discovery, 2009-03, Vol.8 (3), p.197-202

2009

Volltextzugriff (PDF)

Update Lessons from Positron Emission Tomography Imaging Part I: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antipsychotics

Therapeutic drug monitoring, 2024-02, Vol.46 (1), p.16-32

2024

Volltextzugriff (PDF)

Oxytocin Influences Processing of Socially Relevant Cues in the Ventral Tegmental Area of the Human Brain

Biological psychiatry (1969), 2013-08, Vol.74 (3), p.172-179

2013

Volltextzugriff (PDF)

Wie Wollen Wir Leben?: Über Unsere Zukunft Entscheiden Wir Selbst

Grunder, Gerhard

1st Aufl 2020 edition, 2020

Volltextzugriff (PDF)

Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants

Therapeutic drug monitoring, 2024-04, Vol.46 (2), p.155-169

2024

Volltextzugriff (PDF)

Dissociation of neural networks for anticipation and consumption of monetary and social rewards

NeuroImage (Orlando, Fla.), 2010-02, Vol.49 (4), p.3276-3285

2010

Volltextzugriff (PDF)

Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance

Frontiers in psychiatry, 2020-02, Vol.11, p.5-5

2020

Volltextzugriff (PDF)

Digitale Phänotypisierung. Kontra

Nervenarzt, 2020-09, Vol.91 (9), p.860-862

Gründer, Gerhard

2020

Volltextzugriff (PDF)

Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis

Psychopharmacology, 2022-11, Vol.239 (11), p.3377-3391

2022

Volltextzugriff (PDF)

The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development

Neuropsychopharmacology (New York, N.Y.), 2009-01, Vol.34 (1), p.187-203

2009

Volltextzugriff (PDF)

Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)

Journal of psychopharmacology (Oxford), 2024-05, Vol.38 (5), p.432-457

2024

Volltextzugriff (PDF)

Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women

Social cognitive and affective neuroscience, 2009-06, Vol.4 (2), p.158-165

2009

Volltextzugriff (PDF)

Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis

Journal of psychopharmacology (Oxford), 2021-03, Vol.35 (3), p.273-278

2021

Volltextzugriff (PDF)

Psychedelics: A New Treatment Paradigm in Psychiatry?

Pharmacopsychiatry, 2021-07, Vol.54 (4), p.149-150

Gründer, Gerhard

2021

Volltextzugriff (PDF)

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians

The world journal of biological psychiatry, 2018-04, Vol.19 (3), p.162-174

2018

Volltextzugriff (PDF)

“Absolute” or “relative”: Choosing the right outcome measure in neuroimaging

NeuroImage (Orlando, Fla.), 2009-04, Vol.45 (2), p.258-259

Gründer, Gerhard

2009

Volltextzugriff (PDF)

How Do We Want to Live?: We Decide Ourselves About Our Future

Gründer, Gerhard

Volltextzugriff (PDF)

Baseline monocyte count predicts symptom improvement during intravenous ketamine therapy in treatment-resistant depression: a single-arm open-label observational study

Frontiers in psychiatry, 2024-06, Vol.15, p.1415505

2024

Volltextzugriff (PDF)

Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice

Frontiers in psychiatry, 2022-04, Vol.13, p.832209-832209

2022

Volltextzugriff (PDF)

Prefrontal and striatal dopamine D2/D3 receptors correlate with fMRI BOLD activation during stopping

Brain imaging and behavior, 2022-02, Vol.16 (1), p.186-198

2022

Volltextzugriff (PDF)

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

Frontiers in psychiatry, 2022-02, Vol.13, p.826138-826138

2022

Volltextzugriff (PDF)

The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males

The Journal of neuroscience, 2013-10, Vol.33 (43), p.16889-16896

2013

Volltextzugriff (PDF)

The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia

British journal of clinical pharmacology, 2022-07, Vol.88 (7), p.3193-3200

2022

Volltextzugriff (PDF)

Peripheral Oxytocin Predicts Higher-Level Social Cognition in Men Regardless of Empathy Quotient

Pharmacopsychiatry, 2019-03, Vol.52 (3), p.148-154

2019

Volltextzugriff (PDF)

1 – 25 von 347

Suche als RSS-Feed

Aktive Filter

ThemaMedicine: General Issues

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(266)

Publikationsform

Sprache

Englisch
(267)
Deutsch
(79)
Japanisch
(22)
Spanisch
(2)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How Do We Want to Live?: We Decide Ourselves about Our Future

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

Update Lessons from Positron Emission Tomography Imaging Part I: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antipsychotics

Oxytocin Influences Processing of Socially Relevant Cues in the Ventral Tegmental Area of the Human Brain

Wie Wollen Wir Leben?: Über Unsere Zukunft Entscheiden Wir Selbst

Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants

Dissociation of neural networks for anticipation and consumption of monetary and social rewards

Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance

Digitale Phänotypisierung. Kontra

Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis

The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development

Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)

Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women

Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis

Psychedelics: A New Treatment Paradigm in Psychiatry?

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians

“Absolute” or “relative”: Choosing the right outcome measure in neuroimaging

How Do We Want to Live?: We Decide Ourselves About Our Future

Baseline monocyte count predicts symptom improvement during intravenous ketamine therapy in treatment-resistant depression: a single-arm open-label observational study

Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice

Prefrontal and striatal dopamine D2/D3 receptors correlate with fMRI BOLD activation during stopping

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males

The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia

Peripheral Oxytocin Predicts Higher-Level Social Cognition in Men Regardless of Empathy Quotient

Aktive Filter

Suchergebnisse filtern